Vanda CEO to Newsmax: Drug May Ease GLP-1 Nausea
Vanda Pharmaceuticals CEO Mihael Polymeropoulos told Newsmax on Thursday that the company's recently approved motion sickness drug, Nereus, could help people taking popular GLP-1 medications manage nausea and vomiting, potentially allowing them to remain on treatment. On "Bianca Across the…